HUTCHMED (China) Ltd

Common Name

HUTCHMED (China)

Country

Hong Kong

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,780

Ticker

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.hutch-med.com

Description

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the... Show more

Income Statement Balance Sheet Group Entities

HUTCHMED (China)'s Financial Statements Preview

Below are the financial statements of HUTCHMED (China), including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	153.96^a	283.59^a
Short-term investments	682.15^a	602.75^a
Accounts receivable	155.54^a	116.89^a
Other receivables, prepayments and deposits	16.61^a	14.89^a
Amounts due from related parties	7.9^a	28.46^a
Inventories	50.4^a	50.26^a
Total current assets	1,066.56^a	1,096.84^a
Property, plant and equipment	92.5^a	99.73^a
Right-of-use assets	4.5^a	4.67^a
Deferred tax assets	12.45^a	15.46^a
Investment in an equity investee	77.77^a	48.41^a
Investment in equity security	5^a	0^a
Other non-current assets	15.43^a	14.68^a
Total assets	1,274.2^a	1,279.77^a
Liabilities and shareholders’ equity	—	—
Current liabilities	—	—
Accounts payable	42.52^a	36.33^a
Other payables, accruals and advance receipts	256.12^a	271.4^a
Short-term bank borrowings	23.37^a	31.16^a
Deferred revenue	50.07^a	57.64^a
Income tax payable	1.55^a	2.58^a
Lease liabilities	2.93^a	3.93^a
Total current liabilities	376.56^a	403.03^a
Lease liabilities, non-current portion	4.09^a	2.86^a
Deferred tax liabilities	2.99^a	1.48^a
Long-term bank borrowings	59.43^a	48.19^a
Deferred revenue, non-current portion	48.43^a	69.48^a
Other non-current liabilities	10.84^a	11.35^a
Total liabilities	502.34^a	536.39^a
Company’s shareholders’ equity	—	—
Ordinary shares	87.16^a	87.13^a
Additional paid-in capital	1,517.53^a	1,522.45^a
Accumulated losses	-833.17^a	-870.87^a
Accumulated other comprehensive loss	-11.59^a	-8.16^a
Total company’s shareholders’ equity	759.93^a	730.54^a
Non-controlling interests	11.92^a	12.85^a
Total shareholders’ equity	771.85^a	743.39^a
Total liabilities and shareholders’ equity	1,274.2^a	1,279.77^a

Download Data

Verified Sources Behind HUTCHMED (China)’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore HUTCHMED (China)’s data sources below and access millions more through our Disclosure Search.

a. HUTCHMED (China)'s Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

HUTCHMED (China) Ltd

HUTCHMED (China)'s Financial Statements Preview

Verified Sources Behind HUTCHMED (China)’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

China Resources Pharmaceutical Group Ltd

Piramal Pharma Ltd

Gland Pharma Ltd

Alkem Laboratories Ltd

IPCA Laboratories Ltd

Tasly Pharmaceutical Group Co Ltd